
Summit Therapeutics PLC (SMMT)
US$ 24.290.37%
Price Chart
Key Statistics
Market Cap
$ 18.11B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
3.1M
52W High
$ 36.91
52W Low
$ 2.10
Dividend Yield
0.00%
Beta
-0.95
Technicals
50-Day MA
22.6337
200-Day MA
19.8009
52 Week High
36.91
52 Week Low
2.1
About SMMT
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.
Employees
159
Headquarters
Miami, FL
CEO
Mr. Robert W. Duggan
Latest News
Summit Therapeutics: New Ivonescimab Data Raise Concerns (NASDAQ:SMMT) - Seeking Alpha
4 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg